Big surge coming in for pharma firm Natco Pharma as the company has gotten a nod from the drug regulator to begin production of antifungal drug Amphotericin B injection, used inthe treatment of Mucormycosis, also called 'Black Fungus'.
Natco Pharma hit a 52 week high as more good news poured in, the company also confirmed that it had started phase-III clinical trials of Molnupiravir, a drug used to treat mild Covid-19. The clinical trial is planned in 32 hospitals across the country.